A Study Evaluating Desvenlafaxine Sustained Release (DVS SR) in Adult Female Outpatients With Fibromyalgia
Public ClinicalTrials.gov record NCT00696787. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Pregabalin-Referenced, Parallel-Group, Adaptive Design Study of DVS SR in Adult Female Outpatients With Fibromyalgia Syndrome
Study identification
- NCT ID
- NCT00696787
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Industry
- Enrollment
- 125 participants
Conditions and interventions
Conditions
Interventions
- Desvenlafaxine Sustained Release (DVS SR) Drug
- Lyrica® (Pregabalin) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2008
- Primary completion
- Dec 31, 2008
- Completion
- Dec 31, 2008
- Last update posted
- Feb 24, 2013
2008 – 2009
United States locations
- U.S. sites
- 27
- U.S. states
- 15
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | 35801 | — |
| Not listed | Roseville | California | 95661 | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | San Diego | California | 92128 | — |
| Not listed | Santa Ana | California | 92705 | — |
| Not listed | Walnut Creek | California | 94598 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Tampa | Florida | 33606 | — |
| Not listed | Decatur | Georgia | 30033 | — |
| Not listed | Evansville | Indiana | 47714 | — |
| Not listed | Indianapolis | Indiana | 46260 | — |
| Not listed | Lexington | Kentucky | 40509 | — |
| Not listed | Rockville | Maryland | 20852 | — |
| Not listed | Lansing | Michigan | 48910 | — |
| Not listed | Raleigh | North Carolina | 27612 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Dayton | Ohio | 45408 | — |
| Not listed | Duncansville | Pennsylvania | 16635 | — |
| Not listed | Philadelphia | Pennsylvania | 19152 | — |
| Not listed | Chattanooga | Tennessee | 37404 | — |
| Not listed | Chattanooga | Tennessee | 37421 | — |
| Not listed | Knoxville | Tennessee | 37920 | — |
| Not listed | Austin | Texas | 78756 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | San Antonio | Texas | 78205 | — |
| Not listed | Salt Lake City | Utah | 84102 | — |
| Not listed | Middleton | Wisconsin | 53562 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00696787, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 24, 2013 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00696787 live on ClinicalTrials.gov.